fangchinoline has been researched along with Cancer of Stomach in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, D; Li, D; Tian, F | 1 |
1 other study(ies) available for fangchinoline and Cancer of Stomach
| Article | Year |
|---|---|
Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells.
Topics: Antineoplastic Agents; Benzylisoquinolines; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Stomach Neoplasms | 2015 |